Respiratory Illnesses and Prevention

Medium

About Respiratory Illness Vaccines

Medium
h2
Left
About Respiratory Illness Vaccines

  • Options: A vaccine that targets 3 strains of flu, updated annually
  • Eligibility: Ages 6 months+ (AAP) (AAFP) (ACOG) (CDC)
  • Effectiveness: Reduces risk of hospitalization and health care visits by 30-60%
  • When to get: Available throughout flu season; ideal to get by end of October

  • Options: Updated as needed to match dominant strain (Pfizer mRNA, Moderna mRNA, Novavax)
  • Eligibility:
  • Effectiveness: Reduces risk of severe illness by 30-60%
  • When to get: Available any time, discuss timing with your provider

  • Options: GSK, Pfizer, Moderna (mRNA)
  • Eligibility: Ages 75 years+ and ages 50-74 years at high risk; only one lifetime dose (at this time) (AAFP) (CDC)
  • Effectiveness: Reduces risk of severe illness by 82-86%
  • When to get: Anytime (summer or fall may be best), discuss with your provider

  • Options: Pfizer
  • Eligibility: Pregnant people who have not received a dose during a previous pregnancy (protection will pass to baby for first 6 months of life) (AAFP) (ACOG) (CDC)
  • Effectiveness: Reduces risk of severe illness in first 3 months of life by 82%
  • When to get: September-January, during 32-36 weeks gestation

  • Options: Nirsevimab (Sanofi) or Clesrovimab (Merk)
  • Eligibility:
    • Infants born during RSV season within first 7 days of life (AAP) (AAFP) (CDC)
    • Infants ages <8 months entering their first RSV season (AAP) (AAFP) (CDC)
    • Children ages 8-19 months entering second RSV season at higher risk, including all American Indian children (AAP) (AAFP) (CDC)
  • Effectiveness: 80-96% effective against hospitalization
  • When to get: October - March
Medium
Chart outlining information about respiratory illness immunizations
Medium
Medium
Medium

Medium

Medium